BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12068535)

  • 1. Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation.
    Garcia RF; Morales E; Garcia CE; Saksena S; Hübscher SG; Elias E
    Arq Gastroenterol; 2001; 38(4):247-53. PubMed ID: 12068535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting.
    Balitzer D; Tsai JH; Gill RM
    Diagn Pathol; 2022 Aug; 17(1):65. PubMed ID: 35948927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.
    Carson K; Washington MK; Treem WR; Clavien PA; Hunt CM
    Liver Transpl Surg; 1997 Mar; 3(2):174-6. PubMed ID: 9346732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.
    Molloy RM; Komorowski R; Varma RR
    Liver Transpl Surg; 1997 Mar; 3(2):177-8. PubMed ID: 9346733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
    Pais R; Charlotte F; Fedchuk L; Bedossa P; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2013 Sep; 59(3):550-6. PubMed ID: 23665288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic steatohepatitis and liver transplantation.
    Gitto S; Vukotic R; Vitale G; Pirillo M; Villa E; Andreone P
    Dig Liver Dis; 2016 Jun; 48(6):587-91. PubMed ID: 27038703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of non-alcoholic steatohepatitis.
    Reid BM; Sanyal AJ
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1117-22. PubMed ID: 15489568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo non-alcoholic fatty liver disease following orthotopic liver transplantation.
    Poordad F; Gish R; Wakil A; Garcia-Kennedy R; Martin P; Yao FY
    Am J Transplant; 2003 Nov; 3(11):1413-7. PubMed ID: 14525603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
    Brunt EM; Ramrakhiani S; Cordes BG; Neuschwander-Tetri BA; Janney CG; Bacon BR; Di Bisceglie AM
    Mod Pathol; 2003 Jan; 16(1):49-56. PubMed ID: 12527713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.
    Morita Y; Ueno T; Sasaki N; Kuhara K; Yoshioka S; Tateishi Y; Nagata E; Kage M; Sata M
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):277S-81S. PubMed ID: 16385236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity: danger for the hepatocytes?].
    Selvais PL; Henrion J
    Acta Clin Belg; 1992; 47(5):329-37. PubMed ID: 1334321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: Non-alcoholic fatty liver disease.
    Alba LM; Lindor K
    Aliment Pharmacol Ther; 2003 Apr; 17(8):977-86. PubMed ID: 12694079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.